Sadoff JC - Search Results

1

Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.

Opal SM, Cross AS, Kelly NM, Sadoff JC, Bodmer MW, Palardy JE, Victor GH. Opal SM, et al. Among authors: sadoff jc. J Infect Dis. 1990 Jun;161(6):1148-52. doi: 10.1093/infdis/161.6.1148. J Infect Dis. 1990. PMID: 2140582

2

Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa.

Collins HH, Cross AS, Dobek A, Opal SM, McClain JB, Sadoff JC. Collins HH, et al. Among authors: sadoff jc. J Infect Dis. 1989 Jun;159(6):1073-82. doi: 10.1093/infdis/159.6.1073. J Infect Dis. 1989. PMID: 2723454

3

The efficacy of combination immunotherapy in experimental Pseudomonas sepsis.

Cross AS, Opal SM, Palardy JE, Bodmer MW, Sadoff JC. Cross AS, et al. Among authors: sadoff jc. J Infect Dis. 1993 Jan;167(1):112-8. doi: 10.1093/infdis/167.1.112. J Infect Dis. 1993. PMID: 8418157

4

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.

Opal SM, Cross AS, Sadoff JC, Collins HH, Kelly NM, Victor GH, Palardy JE, Bodmer MW. Opal SM, et al. Among authors: sadoff jc. J Clin Invest. 1991 Sep;88(3):885-90. doi: 10.1172/JCI115390. J Clin Invest. 1991. PMID: 1885775 Free PMC article.

5

The human antibody response during natural bacteremic infection with gram-negative bacilli against lipopolysaccharide core determinants.

Cross AS, Sidberry H, Sadoff JC. Cross AS, et al. Among authors: sadoff jc. J Infect Dis. 1989 Aug;160(2):225-36. doi: 10.1093/infdis/160.2.225. J Infect Dis. 1989. PMID: 2474616

6

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P. Cross AS, et al. Among authors: sadoff jc. J Exp Med. 1989 Jun 1;169(6):2021-7. doi: 10.1084/jem.169.6.2021. J Exp Med. 1989. PMID: 2659724 Free PMC article.

7

Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans.

Cross AS, Sadoff JC, Iglewski BH, Sokol PA. Cross AS, et al. Among authors: sadoff jc. J Infect Dis. 1980 Oct;142(4):538-46. doi: 10.1093/infdis/142.4.538. J Infect Dis. 1980. PMID: 6777437

8

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.

Bhattacharjee AK, Opal SM, Taylor R, Naso R, Semenuk M, Zollinger WD, Moran EE, Young L, Hammack C, Sadoff JC, Cross AS. Bhattacharjee AK, et al. Among authors: sadoff jc. J Infect Dis. 1996 May;173(5):1157-63. doi: 10.1093/infdis/173.5.1157. J Infect Dis. 1996. PMID: 8627067

9

Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.

Cryz SJ Jr, Fürer E, Sadoff JC, Fredeking T, Que JU, Cross AS. Cryz SJ Jr, et al. Among authors: sadoff jc. J Infect Dis. 1991 May;163(5):1055-61. doi: 10.1093/infdis/163.5.1055. J Infect Dis. 1991. PMID: 1902245

10

Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.

Kim KS, Kang JH, Cross AS, Kaufman B, Zollinger W, Sadoff J. Kim KS, et al. J Infect Dis. 1988 Jan;157(1):47-53. doi: 10.1093/infdis/157.1.47. J Infect Dis. 1988. PMID: 2447199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters